Franklin Covey earnings missed by $0.43, revenue fell short of estimates

Franklin Covey (NYSE: FC) reported third-quarter results significantly below analyst expectations, posting an EPS of $-0.11 against an estimated $0.32 and revenue of $67.1 million versus a $77.39 million consensus. The company also provided FY 2025 revenue guidance in the range of $265.00 million to $275.00 million. This substantial earnings and revenue miss follows two recent negative EPS revisions, signaling a notable underperformance relative to market forecasts, despite the stock's 17% gain over the past three months.

Analysis

Franklin Covey reported a significant third-quarter miss on both earnings and revenue, signaling substantial operational weakness. The reported loss per share of $0.11 was a stark contrast to the consensus analyst estimate of a $0.32 profit, while revenue of $67.1 million fell well short of the expected $77.39 million. This underperformance was preceded by two negative EPS revisions over the past 90 days, indicating that analyst sentiment was already deteriorating. The poor results create a sharp disconnect with the stock's recent performance, which saw a 17% gain over the last three months, though it remains down 38.08% over the past year. In a conflicting signal, the company's financial health is rated as "great performance," suggesting underlying balance sheet strength may exist despite the severe earnings disappointment. The company has issued FY 2025 revenue guidance of $265.00 million to $275.00 million, which will now be the key benchmark for evaluating its recovery prospects.

Key Decisions for Investors

• Given the magnitude of the earnings and revenue miss, investors should anticipate immediate negative pressure on the stock, especially considering its recent 17% run-up which now appears disconnected from fundamentals.
• It is critical to investigate the discrepancy between the poor quarterly performance and the "great" financial health score to determine if balance sheet strength can mitigate the operational weakness.
• Monitor upcoming analyst revisions closely, as the new FY 2025 revenue guidance will be re-evaluated in the context of this quarter's miss, likely leading to further downward adjustments to forecasts.